Published in Biochem J on December 15, 1986
Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen. Am J Hum Genet (1988) 3.00
Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. Proc Natl Acad Sci U S A (1990) 1.56
Tight regulation of wingless-type signaling in the articular cartilage - subchondral bone biomechanical unit: transcriptomics in Frzb-knockout mice. Arthritis Res Ther (2012) 1.52
ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta. PLoS Genet (2008) 1.37
Regulation of procollagen synthesis and processing during ascorbate-induced extracellular matrix accumulation in vitro. Biochem J (1990) 1.12
A nonsense mutation in the carboxyl-terminal domain of type X collagen causes haploinsufficiency in schmid metaphyseal chondrodysplasia. J Clin Invest (1998) 1.09
Characterisation of a glycine to valine substitution at amino acid position 910 of the triple helical region of type III collagen in a patient with Ehlers-Danlos syndrome type IV. J Med Genet (1991) 1.03
Myocardial infarction resulting from coronary artery dissection in an adolescent with Ehlers-Danlos syndrome type IV due to a type III collagen mutation. Br Heart J (1995) 1.02
The clinical features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by arginine in the pro alpha 1(I) chain of type I procollagen. J Med Genet (1990) 1.01
The clinical features of osteogenesis imperfecta resulting from a non-functional carboxy terminal pro alpha 1(I) propeptide of type I procollagen and a severe deficiency of normal type I collagen in tissues. J Med Genet (1990) 0.98
Assessment of procollagen processing defects by fibroblasts cultured in the presence of dextran sulphate. Biochem J (1990) 0.96
Perinatal lethal osteogenesis imperfecta. J Med Genet (1995) 0.96
The clinicopathological features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by valine in the pro alpha 1 (I) chain of type I procollagen. J Med Genet (1992) 0.94
Characterization of a type II collagen gene (COL2A1) mutation identified in cultured chondrocytes from human hypochondrogenesis. Proc Natl Acad Sci U S A (1992) 0.92
Human-mouse interspecies collagen I heterotrimer is functional during embryonic development of Mov13 mutant mouse embryos. Mol Cell Biol (1990) 0.90
Changes in collagen stability and folding in lethal perinatal osteogenesis imperfecta. The effect of alpha 1 (I)-chain glycine-to-arginine substitutions. Biochem J (1989) 0.86
Abnormal type III collagen produced by an exon-17-skipping mutation of the COL3A1 gene in Ehlers-Danlos syndrome type IV is not incorporated into the extracellular matrix. Biochem J (1995) 0.84
Characterization of three osteogenesis imperfecta collagen alpha 1(I) glycine to serine mutations demonstrating a position-dependent gradient of phenotypic severity. Biochem J (1992) 0.82
Increased expression of the gene for the pro alpha 1(IV) chain of basement-membrane procollagen in cultured skin fibroblasts from two variants of osteogenesis imperfecta. Biochem J (1989) 0.78
Pulse-chase analysis of procollagen biosynthesis by azidohomoalanine labeling. Connect Tissue Res (2014) 0.78
Disrupted growth plates and progressive deformities in osteogenesis imperfecta as a result of the substitution of glycine 585 by valine in the alpha 2 (I) chain of type I collagen. J Med Genet (1996) 0.78
Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients. Biochem J (1992) 0.77
A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem (1974) 113.22
Genetic heterogeneity in osteogenesis imperfecta. J Med Genet (1979) 12.51
Heritable diseases of collagen. N Engl J Med (1984) 4.39
(Alpha1(3))3 human skin collagen. Release by pepsin digestion and preponderance in fetal life. J Biol Chem (1974) 3.83
The estimation of two collagens from human dermis by interrupted gel electrophoresis. Biochem Biophys Res Commun (1976) 3.22
A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem (1981) 2.85
Fetal membrane collagens: identification of two new collagen alpha chains. Proc Natl Acad Sci U S A (1976) 2.71
Type I osteogenesis imperfecta: a nonfunctional allele for pro alpha 1 (I) chains of type I procollagen. Proc Natl Acad Sci U S A (1982) 2.45
Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta. J Biol Chem (1985) 2.45
On the significance of the extractable collagens. J Biophys Biochem Cytol (1960) 2.12
Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta. Biochem J (1984) 1.98
Osteogenesis imperfecta congenita: evidence for a generalized molecular disorder of collagen. Lab Invest (1977) 1.57
The separation and characterization of the alpha- and beta-components of calf skin collagen. J Biol Chem (1960) 1.47
The cyanogen bromide peptides of bovine soluble and insoluble collagens. I. Characterization of peptides from soluble type I collagen by sodium dodecylsulphate polyacrylamide gel electrophoresis. Connect Tissue Res (1976) 1.39
Changes in crosslinking during aging in bovine tendon collagen. FEBS Lett (1979) 1.26
Collagen composition of normal and myxomatous human mitral heart valves. Biochem J (1984) 1.25
Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta. J Clin Invest (1985) 1.24
Analysis of the heterogeneity of human collagens by two-dimensional polyacrylamide-gel electrophoresis. Biochem J (1981) 1.09
Osteogenesis imperfecta (lethal) bones contain types III and V collagens. J Clin Pathol (1980) 1.08
A comprehensive approach to the study of collagen primary structure based on high-performance liquid chromatography. Eur J Biochem (1982) 1.04
Separation of type III collagen from type I collagen and pepsin by differential denaturation and renaturation. Biochem Biophys Res Commun (1978) 1.04
Rapid fractionation of collagen chains and peptides by high-performance liquid chromatography. Anal Biochem (1986) 0.98
Chemical and immunological properties of reduced and alkylated polypeptide chains of bovine fibrinogen. Eur J Biochem (1972) 0.96
Osteogenesis imperfecta: phenotypic heterogeneity, protein suicide, short and long collagen. Am J Hum Genet (1984) 0.96
Osteogenesis imperfecta: biochemical studies of bone collagen. Clin Orthop Relat Res (1977) 0.93
Quantitation of type I and III collagens using electrophoresis of alpha chains and cyanogen bromide peptides. Anal Biochem (1984) 0.91
Location of the intermolecular cross-links in bovine dentin collagen, solubilization with trypsin and isolation of cross-link peptides containing dihydroxylysinonorleucine and pyridinoline. Biochem Biophys Res Commun (1981) 0.88
The presence of intermolecular disulfide cross-links in type III collagen. J Biol Chem (1983) 0.87
Nonmineralized and mineralized compartments of bone: the role of pyridinoline in nonmineralized collagen. Biochem Biophys Res Commun (1983) 0.86
Analysis of cyanogen bromide peptides of type I collagen from a patient with lethal osteogenesis imperfecta. Biochem J (1983) 0.83
An unusual pattern of peptide-bound lysine metabolism in collagen from an infant with lethal perinatal osteogenesis imperfecta. J Clin Invest (1984) 0.82
The use of 2-dimensional CNBr peptide maps for the analysis of crosslinked peptides in bone collagen. Coll Relat Res (1981) 0.81
Scanning electron microscopy findings in osteogenesis imperfecta fetalis. Isr J Med Sci (1977) 0.80
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell (1997) 7.47
From meaning to term: semantic locality in the UMLS Metathesaurus. Proc Annu Symp Comput Appl Med Care (1991) 4.59
Navigating to knowledge. Methods Inf Med (1995) 3.69
ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet (1998) 3.66
Metaphrase: an aid to the clinical conceptualization and formalization of patient problems in healthcare enterprises. Methods Inf Med (1998) 3.24
Standardized problem list generation, utilizing the Mayo canonical vocabulary embedded within the Unified Medical Language System. Proc AMIA Annu Fall Symp (1997) 2.93
Merging terminologies. Medinfo (1995) 2.91
Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene. Nature (1988) 2.49
Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. N Engl J Med (1996) 2.30
Design of an efficient position sensitive gamma ray detector for nuclear medicine. Phys Med Biol (1986) 2.20
Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage (2011) 2.06
MEME-II supports the cooperative management of terminology. Proc AMIA Annu Fall Symp (1996) 2.06
Procollagen folding and assembly: the role of endoplasmic reticulum enzymes and molecular chaperones. Semin Cell Dev Biol (1999) 2.01
Screening and management of renal disease in human immunodeficiency virus-infected patients in Australia. Intern Med J (2013) 2.01
Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta. Biochem J (1984) 1.98
Formal properties of the Metathesaurus. Proc Annu Symp Comput Appl Med Care (1994) 1.97
Technical basis for EPA's proposed regulation on the cleanup of sites contaminated with radioactivity. Health Phys (1996) 1.92
Do physicians do as they say? The case of mammography. Arch Fam Med (1997) 1.85
Streptococcus iniae, a human and animal pathogen: specific identification by the chaperonin 60 gene identification method. J Clin Microbiol (1998) 1.75
Bedside emergency department ultrasonography plus radiography of the kidneys, ureters, and bladder vs intravenous pyelography in the evaluation of suspected ureteral colic. Acad Emerg Med (1998) 1.74
Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. J Cell Biol (1998) 1.69
Pitt-Rogers-Danks syndrome: the result of a 4p microdeletion. Am J Med Genet (1996) 1.67
Reliability of radiological measurements in the assessment of the child's hip. J Bone Joint Surg Br (1989) 1.66
Pharmacokinetics of fosinopril in patients with various degrees of renal function. Clin Pharmacol Ther (1991) 1.62
Paramedic vs private transportation of trauma patients. Effect on outcome. Arch Surg (1996) 1.61
Anaesthesia for children with mucopolysaccharidoses. Anaesth Intensive Care (1996) 1.60
The utility of radioiodine uptake and thyroid scintigraphy in the diagnosis and management of hyperthyroidism. Clin Endocrinol (Oxf) (2009) 1.57
Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. Proc Natl Acad Sci U S A (1990) 1.56
Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen. J Biol Chem (1987) 1.54
Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals. Clin Infect Dis (2014) 1.51
Accident Prevention. Am J Public Health Nations Health (1946) 1.50
Validation of preferences for life-sustaining treatment: implications for advance care planning. Ann Intern Med (1997) 1.50
Mutation analysis of LMX1B gene in nail-patella syndrome patients. Am J Hum Genet (1998) 1.49
Prosthetic replacement of the distal femur for primary bone tumours. J Bone Joint Surg Br (1991) 1.49
A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV. J Biol Chem (1990) 1.47
Validity of the US Behavioral Risk Factor Surveillance System's health related quality of life survey tool in a group of older Canadians. Chronic Dis Can (2001) 1.47
Screening for congenital dislocation of the hip in Australia. J Paediatr Child Health (1991) 1.45
The six-minute walk test in healthy children: reliability and validity. Eur Respir J (2005) 1.44
The dopamine transporter gene and Parkinson's disease in a Chinese population. Neurology (1997) 1.43
Characterization of point mutations in the collagen COL1A1 and COL1A2 genes causing lethal perinatal osteogenesis imperfecta. J Biol Chem (1989) 1.42
Ultrasound training for emergency physicians--a prospective study. Acad Emerg Med (2000) 1.42
Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VII. J Biol Chem (1986) 1.41
Efficacy of multidisciplinary approach in treatment of constipation: a pilot study. Hong Kong Med J (2006) 1.37
Waist circumference and body mass index in Chinese children: cutoff values for predicting cardiovascular risk factors. Int J Obes (Lond) (2006) 1.37
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer. Ann Oncol (2012) 1.34
A frameshift mutation results in a truncated nonfunctional carboxyl-terminal pro alpha 1(I) propeptide of type I collagen in osteogenesis imperfecta. J Biol Chem (1989) 1.34
Medical complications of achondroplasia: a multicentre patient review. J Med Genet (1998) 1.34
Identification of Enterococcus species and phenotypically similar Lactococcus and Vagococcus species by reverse checkerboard hybridization to chaperonin 60 gene sequences. J Clin Microbiol (2000) 1.34
Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. Am J Hum Genet (1998) 1.33
Long-term retrograde amnesia...the crucial role of the hippocampus. Neuropsychologia (2001) 1.31
Missense mutations in the beta strands of the single A-domain of matrilin-3 result in multiple epiphyseal dysplasia. J Med Genet (2004) 1.30
Introduction of the human pro alpha 1(I) collagen gene into pro alpha 1(I)-deficient Mov-13 mouse cells leads to formation of functional mouse-human hybrid type I collagen. Proc Natl Acad Sci U S A (1987) 1.30
Reduced collagen VI causes Bethlem myopathy: a heterozygous COL6A1 nonsense mutation results in mRNA decay and functional haploinsufficiency. Hum Mol Genet (1998) 1.28
Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS. Clin Genet (2004) 1.27
Incomplete healing of simple bone cysts after steroid injections. J Bone Joint Surg Br (1997) 1.27
beta-hydroxyisobutyryl coenzyme A deacylase deficiency: a defect in valine metabolism associated with physical malformations. Pediatrics (1982) 1.27
Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase II. J Biol Chem (1989) 1.27
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up. Br J Dermatol (2013) 1.26
A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I). Hum Mol Genet (1996) 1.26
Pregnancy, birth, and disability: women's health care experiences. Health Care Women Int (2000) 1.26
The effects of obesity on pulmonary function. Arch Dis Child (2003) 1.26
Autoantibodies to type II collagen: occurrence in rheumatoid arthritis, other arthritides, autoimmune connective tissue diseases, and chronic inflammatory syndromes. Ann Rheum Dis (1988) 1.26
Collagen composition of normal and myxomatous human mitral heart valves. Biochem J (1984) 1.25
Three weeks of Kirschner wire fixation for displaced lateral condylar fractures of the humerus in children. J Pediatr Orthop (2001) 1.23
Increased nerve-growth-factor beta-chain cross-reacting material in familial dysautonomia. N Engl J Med (1976) 1.23
Paternal age effect in fibrodysplasia ossificans progressiva. J Med Genet (1979) 1.23
Characterization of an arginine 789 to cysteine substitution in alpha 1 (II) collagen chains of a patient with spondyloepiphyseal dysplasia. J Biol Chem (1993) 1.23
Normal skeletal development of mice lacking matrilin 1: redundant function of matrilins in cartilage? Mol Cell Biol (1999) 1.21
Substitution of arginine for glycine 664 in the collagen alpha 1(I) chain in lethal perinatal osteogenesis imperfecta. Demonstration of the peptide defect by in vitro expression of the mutant cDNA. J Biol Chem (1988) 1.21
Mammalian skeletogenesis and extracellular matrix: what can we learn from knockout mice? Cell Struct Funct (2000) 1.21
Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type I. Hum Mol Genet (1998) 1.19
Mannose-binding lectin and rheumatoid arthritis in southern Chinese. Arthritis Rheum (2000) 1.19
Bethlem myopathy and engineered collagen VI triple helical deletions prevent intracellular multimer assembly and protein secretion. J Biol Chem (1999) 1.19
Medial physeal stapling for primary and secondary genu valgum in late childhood and adolescence. J Bone Joint Surg Br (1995) 1.18
Treatment of acute osteomyelitis in childhood. J Bone Joint Surg Br (1982) 1.18
The effect of relaxin on collagen metabolism in the nonpregnant rat pubic symphysis: the influence of estrogen and progesterone in regulating relaxin activity. Endocrinology (1996) 1.17
The mucopolysaccharidoses. Aust Paediatr J (1987) 1.17